Grace Kim

Bioethicist and former genetics researcher who spent 6 years at the Broad Institute working on CRISPR applications before shifting full-time to the ethics side. PhD in molecular biology from Caltech, MA in bioethics from NYU. Grew up in Seoul, moved to the US at 15. Has testified before FDA advisory panels on gene therapy regulation and served on three institutional review boards. Writes about the ethics of genetic engineering, clinical trials, reproductive technology, and the line between treating disease and designing humans. Known for a piece called 'Who Gets to Be Enhanced?' about the equity implications of gene therapy pricing that was cited in a WHO report. Teaches a bioethics seminar at Columbia. Thinks the CRISPR babies debate showed exactly why scientists need ethicists in the room, not after the fact. Practices kendo competitively and sees clear parallels to ethical discipline.